-
Netflix countersuit against Broadcom thrown out as patent claims deemed abstract, amendment allowed but not necessarily helpful
Read more: Netflix countersuit against Broadcom thrown out as patent claims deemed abstract, amendment allowed but not necessarily helpfulA strict application of § 101 resulted in the dismissal of one of Netflix’s coutnersuits against Broadcom. An amended complaint would be entertained, though.
-
The Trump Administration is not above the law — but neither is Harvard: patent march-in rights
Read more: The Trump Administration is not above the law — but neither is Harvard: patent march-in rightsWhatever allegations the Trump Administration makes against Harvard and its affiliates may ultimately have to be discussed in court. But Harvard’s compliance is not beyond doubt.
-
BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+
Read more: BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+Pfizer and BioNTech have settled their three-year COVID vaccine-related patent infringement dispute with CureVac in the U.S., granting the latter and its licensing partner GSK $370 million each.
-
NPEs file as few as 10% of ITC Section 337 complaints: agency counsel
Read more: NPEs file as few as 10% of ITC Section 337 complaints: agency counselBetween 70% and 90% of ITC investigations are initiated by non-NPEs, with those numbers generally increasing, while there is a notable shift in the NPEs that do file complaints toward being more innovation-focused.
-
Chinese court enforces $73 million U.S. judgment: door opens for more foreign order enforceability, including UPC
Read more: Chinese court enforces $73 million U.S. judgment: door opens for more foreign order enforceability, including UPCA Chinese order enforcing a U.S. judgment based on reciprocity could mean the Unified Patent Court will no longer require Chinese companies to pay collateral, with the increased possibility that UPC judgments will now be enforced in China too.
-
Access Advance extends early-bird period for video streaming patent license to September 30, 2025: service announcement
Read more: Access Advance extends early-bird period for video streaming patent license to September 30, 2025: service announcementThe early-bird period for implementers taking a license to Access Advance’s Video Distribution Pool has been extended to September 30.
-
Gallium nitride patent wars: Munich I Regional Court grants Infineon second injunction against Innoscience
Read more: Gallium nitride patent wars: Munich I Regional Court grants Infineon second injunction against InnoscienceThe pendulum has swung back in favor of Infineon in its long-running dispute against Innoscience over gallium nitride technology.
-
With UPC lawsuit against Transsion, Huawei joins fellow Access Advance licensors NEC, JVC, Sun Patent Trust in HEVC SEP enforcement
Read more: With UPC lawsuit against Transsion, Huawei joins fellow Access Advance licensors NEC, JVC, Sun Patent Trust in HEVC SEP enforcementAfter settling with Philips over other standards and taking a Via LA pool license (its first pool license ever), Transsion could demonstrate that regional rates indeed facilitate license deals.
Follow Us
Latest Articles
- Bringing collaborative licensing models to the AI revolution will “underpin our growth for the next 5 to 10 years, and beyond”: Via’s Kevin Mack
- SK Nexilis copper-foil patent dispute highlights U.S.-UPC divide over claim construction
- BREAKING: InterDigital wins PI against TCL in Brazil
- USPTO Director again discretionarily denies IPR over petitioner’s purported links to Chinese state
- Proxense sues Mastercard over biometrics patents, expands LG enforcement campaign